[go: up one dir, main page]

Chajra et al., 2015 - Google Patents

Opioid receptor delta as a global modulator of skin differentiation and barrier function repair

Chajra et al., 2015

Document ID
10951591357186238457
Author
Chajra H
Amstutz B
Schweikert K
Auriol D
Redziniak G
Lefevre F
Publication year
Publication venue
International journal of cosmetic science

External Links

Snippet

Objectives The aims of this study were to confirm the properties of selective agonist peptide (Rubixyl) contained in the spinach towards opioid receptor delta. In fact, agonist properties of both spinach peptides (Rubiscolin‐5 and Rubixyl) towards opioid receptor delta were …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids

Similar Documents

Publication Publication Date Title
Chajra et al. Opioid receptor delta as a global modulator of skin differentiation and barrier function repair
Zoladz et al. Differential expression of molecular markers of synaptic plasticity in the hippocampus, prefrontal cortex, and amygdala in response to spatial learning, predator exposure, and stress‐induced amnesia
Proksch et al. The skin: an indispensable barrier
Vinaik et al. NLRP3 inflammasome activity is required for wound healing after burns
Liu et al. TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice
van Geel et al. Koebner’s phenomenon in vitiligo: European position paper
Kotobuki et al. Dysregulation of melanocyte function by Th17‐related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris
Spiekstra et al. Induction of cytokine (interleukin‐1α and tumor necrosis factor‐α) and chemokine (CCL20, CCL27, and CXCL8) alarm signals after allergen and irritant exposure
Sugawara et al. Endocannabinoids limit excessive mast cell maturation and activation in human skin
Rullman et al. Endurance exercise activates matrix metalloproteinases in human skeletal muscle
Fujita et al. A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation
Birder et al. Activation of urothelial transient receptor potential vanilloid 4 by 4α-phorbol 12, 13-didecanoate contributes to altered bladder reflexes in the rat
Nakahigashi et al. Upregulation of aquaporin-3 is involved in keratinocyte proliferation and epidermal hyperplasia
Gennari et al. Sensitive endpoints for evaluating cadmium-induced acute toxicity in LLC-PK1 cells
Gilliver et al. 5α‐Dihydrotestosterone (DHT) retards wound closure by inhibiting re‐epithelialization
Patel et al. Aquaporins in the Skin
Lygoe et al. Role of vitronectin and fibronectin receptors in oral mucosal and dermal myofibroblast differentiation
Wedel et al. SAFit2 reduces neuroinflammation and ameliorates nerve injury-induced neuropathic pain
Parajuli et al. NS309 decreases rat detrusor smooth muscle membrane potential and phasic contractions by activating SK3 channels
Schwartz et al. Hyperosmotic stress contributes to mouse colonic inflammation through the methylation of protein phosphatase 2A
Santana et al. Impaired adrenal medullary function in a mouse model of depression induced by unpredictable chronic stress
Ferri et al. Prostaglandin E2 Mediates Cellular Effects of Interleukin‐1β on Parvocellular Neurones in the Paraventricular Nucleus of the Hypothalamus
Wei et al. TMEM9 mediates IL-6 and IL-1β secretion and is modulated by the Wnt pathway
CN101918037A (en) Methods and compositions for reducing skin damage
Imai et al. Oral malodorous compound inhibits osteoblast proliferation